A Day in the Life…Claire McGuinness

We spoke to Claire McGuinness, Technical Support Manager for Koura about her experience of being a woman in STEM. 

Read More

‘GREEN’ MEDICAL PROPELLANT RECEIVES FDA APPROVAL TO PROCEED TO CLINICAL TRIALS

BOSTON, Feb. 4, 2020 – Koura (previously known as Mexichem Fluor), a pioneer in the development of next generation propellants, today announced FDA approval to proceed to clinical trials with Zephex® 152a. This new medical propellant has been under development for several years for use…

Read More

Third student awarded the Koura Alasdair Sinclair Scholarship

The University of Manchester has announced Melissa Pace as the third student to receive Koura’s Alasdair Sinclair Scholarship.

Read More

Mexichem Fluor showcases courageous new identity

Our parent company has rebranded as Koura to reflect our bold, diverse and progressive new direction as a business. Find out more here.

Read More

DDL 2019 poster available

If you missed it at DDL, you can now download a copy of the poster we displayed at the conference last week. The title of the poster was “Development of HFA-152a as a sustainable pMDI propellant”   Click the link below ZEPHEX_DDL_A0_Artwork

Read More

Koura to supply ground breaking low-carbon footprint medical propellant to Chiesi Farmaceutici for inhalation product development and clinical trials

Landmark multi-million-pound sterling commercial agreement will advance efforts to bring Zephex®152a from the laboratory to the patient   Runcorn (United Kingdom) December 2019 – Koura, the leading medical propellant manufacturer (previously known as Mexichem Fluor), has today announced a commercial agreement to supply the new…

Read More

Koura to showcase world-leading products at DDL 2019

Global innovators and world leaders in medical propellants, Koura, will showcase its industry-leading products at The Drug Delivery to the Lungs (DDL) Conference as a Gold Sponsor.

Read More

Koura sanctions multi million-pound investment into Zephex® 152a facility

Leading medical propellant manufacturer and supplier, Koura, have announced a multi million-pound investment into a new laboratory facility based at their new medical division HQ at Thornton Science Park, Chester, UK. The facility will be the first in the world to offer dedicated pharmaceutical grade…

Read More